Bell Potter and Canaccord Genuity have mailed out pricing for gut health biotech Microba’s $30 million initial public offering, after parading it to fund managers last week.
Two of Perennial Value’s trusts have been given a rating of ‘recommended’. The Perennial Value Shares Wholesale Trust (PVSWT) and the Perennial Concentrated Australian Shares Trust (PCAST) have
Perennial’s Daintree Hybrid Opportunities Fund will be supported by Iress. Iress has announced an expansion to its funds administration partnership with Perennial Value Management. The partnership